tenk.fyi

CRISPR Therapeutics AG

CRSPNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$3.5M

90.6% YoY

Net Income

-$581.6M

58.8% YoY

EPS

$-6.47

49.1% YoY

Cash

$347.6M

16.5% YoY

FY 2025 · As of 2025-12-31